OTCPK:NWKRF - Post by User
Post by
AuroraCannabison Jan 24, 2018 9:58am
141 Views
Post# 27422854
Already up 5%
Already up 5%GT Biopharmaceutical is a world leading developer in many new pharmaceuticals, many which you may depend on one day. GT Biopharmaceutical is a biotechnology company focused on innovative drugs for the treatment of cancer and nervous system diseases (Neurology and Pain) along with other unmet medical needs. Currently GTBP has been trading OTCMKTS but recently (December 18th) applied for a conversion to be traded on the NASDAQ. GT Biopharmaceutical is currently developing a drug to help fight/cure "Myasthenia gravis" which is a chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles, which are responsible for breathing and moving parts of the body, including the arms and legs. They also have a lead oncology drug candidate, OXS-1550 (DT2219)which is a novel bispecific scFv recombinant fusion protein-drug conjugate composed of the variable regions of the heavy and light chains of anti-CD19 and anti-CD22 antibodies and a modified form of diphtheria toxin as its cytotoxic drug payload. Ticker: GTBP (GT Biopharmaceutical)